086060 — Genebiotech Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩35bn
- KR₩29bn
- KR₩83bn
- 59
- 85
- 22
- 59
Annual cashflow statement for Genebiotech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3,432 | -484 | 1,523 | 2,591 | 2,865 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 4,069 | 452 | 135 | 1,459 | 857 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -69.1 | -4,053 | -6,624 | 1,980 | -5,554 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2,492 | -2,841 | -3,679 | 7,369 | -464 |
| Capital Expenditures | -4,395 | -3,115 | -1,174 | -767 | -1,183 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 3,691 | 9,025 | 1,824 | -4,559 | 153 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -704 | 5,910 | 650 | -5,326 | -1,030 |
| Financing Cash Flow Items | -94.1 | -3,247 | — | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,406 | -4,490 | 3,035 | -713 | 2,976 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3,170 | -1,364 | -0.077 | 1,321 | 1,529 |